StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the stock.
Milestone Scientific Trading Down 3.3 %
NYSE:MLSS opened at $0.97 on Monday. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35. The firm has a 50 day moving average of $0.79 and a 200-day moving average of $0.70. The stock has a market capitalization of $74.71 million, a P/E ratio of -9.67 and a beta of 0.89.
Milestone Scientific (NYSE:MLSS – Get Free Report) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($0.02) earnings per share for the quarter. The company had revenue of $2.25 million during the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
- Five stocks we like better than Milestone Scientific
- The Most Important Warren Buffett Stock for Investors: His Own
- First Solar Stock: The Dawn of a New Rally in Share Prices
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- Bank Stocks – Best Bank Stocks to Invest In
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
